TransTissue, founded as a spin-off of the University Hospital Charité in February 2000, has been a subsidiary of BioTissue Technologies, Freiburg since September 2001. With more than 15 years of experience in the field of tissue engineering and regenerative medicine, the scientists and founders of TransTissue have developed second-generation autologous tissue replacements, e.g. cartilage and bone grafts and innovative third-generation cell-free cartilage implants. As a technology company, we focus on inventions and the development of products and treatment strategies in regenerative medicine.
View Top Employees from TransTissue Technologies GmbH| Website | http://www.transtissue.com |
| Revenue | $5.1 million |
| Employees | 3 (2 on RocketReach) |
| Address | 2 Tucholskystraße, Berlin, Berlin 10117, DE |
| Phone | +49 30 450513293 |
| Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Business Services |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular TransTissue Technologies GmbH employee's phone or email?
TransTissue Technologies GmbH Questions
The TransTissue Technologies GmbH annual revenue was $5.1 million in 2023.
2 people are employed at TransTissue Technologies GmbH.
TransTissue Technologies GmbH is based in Berlin, Berlin.
The NAICS codes for TransTissue Technologies GmbH are [54171, 541713, 54, 5417, 541].
The SIC codes for TransTissue Technologies GmbH are [873, 87].
Related Companies
